Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Unemo

Showing results (221-230 of 438) with videos related to

Pageof 44
Sort By:
Journal of Clinical Microbiology|April 5, 2013
Analytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatisSepehr N Tabrizi, Magnus Unemo, Daniel Golparian, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 17, 2022
Extensively drug-resistant (XDR) <i>Neisseria gonorrhoeae</i> causing possible gonorrhoea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022Sonja Pleininger, Alexander Indra, Daniel Golparian, et al.
BMC Infectious Diseases|June 21, 2014
Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--resistance in Neisseria gonorrhoeae during 2009-2012 and NG-MAST genotypes in 2011 and 2012Anna Kubanova, Alexey Kubanov, Nataliya Frigo, et al.
BMC Genomics|December 29, 2017
Mycoplasma genitalium: whole genome sequence analysis, recombination and population structureMaria C Fookes, James Hadfield, Simon Harris, et al.
The Journal of Antimicrobial Chemotherapy|April 30, 2014
Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeaeTomoko Morita-Ishihara, Magnus Unemo, Kei-Ichi Furubayashi, et al.
Scientific Reports|December 6, 2018
Antimicrobial resistance prediction and phylogenetic analysis of Neisseria gonorrhoeae isolates using the Oxford Nanopore MinION sequencerDaniel Golparian, Valentina Donà, Leonor Sánchez-Busó, et al.
Plos One|September 20, 2007
Connector inversion probe technology: a powerful one-primer multiplex DNA amplification system for numerous scientific applicationsMichael S Akhras, Magnus Unemo, Sreedevi Thiyagarajan, et al.
The Lancet Regional Health. Europe|June 9, 2025
Antimicrobial resistance in <i>Neisseria gonorrhoeae</i> and its risk groups in 23 European countries in 2022 within the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP): a retrospective observational studySusanne Jacobsson, Michelle J Cole, Daniel Schröder, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|November 21, 2018
WHO laboratory validation of Xpert<sup>®</sup> CT/NG and Xpert<sup>®</sup> TV on the GeneXpert system verifies high performancesSusanne Jacobsson, Iryna Boiko, Daniel Golparian, et al.
Emerging Infectious Diseases|August 23, 2021
Genomic Epidemiology of Azithromycin-Nonsusceptible Neisseria gonorrhoeae, Argentina, 2005-2019Ricardo Ariel Gianecini, Tomas Poklepovich, Daniel Golparian, et al.
Pageof 44

Showing results (221-230 of 438) with videos related to

Sort By:
Pageof 44
Journal of Clinical Microbiology|April 5, 2013
Analytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatisSepehr N Tabrizi, Magnus Unemo, Daniel Golparian, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 17, 2022
Extensively drug-resistant (XDR) <i>Neisseria gonorrhoeae</i> causing possible gonorrhoea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022Sonja Pleininger, Alexander Indra, Daniel Golparian, et al.
BMC Infectious Diseases|June 21, 2014
Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--resistance in Neisseria gonorrhoeae during 2009-2012 and NG-MAST genotypes in 2011 and 2012Anna Kubanova, Alexey Kubanov, Nataliya Frigo, et al.
BMC Genomics|December 29, 2017
Mycoplasma genitalium: whole genome sequence analysis, recombination and population structureMaria C Fookes, James Hadfield, Simon Harris, et al.
The Journal of Antimicrobial Chemotherapy|April 30, 2014
Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeaeTomoko Morita-Ishihara, Magnus Unemo, Kei-Ichi Furubayashi, et al.
Scientific Reports|December 6, 2018
Antimicrobial resistance prediction and phylogenetic analysis of Neisseria gonorrhoeae isolates using the Oxford Nanopore MinION sequencerDaniel Golparian, Valentina Donà, Leonor Sánchez-Busó, et al.
Plos One|September 20, 2007
Connector inversion probe technology: a powerful one-primer multiplex DNA amplification system for numerous scientific applicationsMichael S Akhras, Magnus Unemo, Sreedevi Thiyagarajan, et al.
The Lancet Regional Health. Europe|June 9, 2025
Antimicrobial resistance in <i>Neisseria gonorrhoeae</i> and its risk groups in 23 European countries in 2022 within the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP): a retrospective observational studySusanne Jacobsson, Michelle J Cole, Daniel Schröder, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|November 21, 2018
WHO laboratory validation of Xpert<sup>®</sup> CT/NG and Xpert<sup>®</sup> TV on the GeneXpert system verifies high performancesSusanne Jacobsson, Iryna Boiko, Daniel Golparian, et al.
Emerging Infectious Diseases|August 23, 2021
Genomic Epidemiology of Azithromycin-Nonsusceptible Neisseria gonorrhoeae, Argentina, 2005-2019Ricardo Ariel Gianecini, Tomas Poklepovich, Daniel Golparian, et al.
Pageof 44